Lisa A. Crawford
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lisa A. Crawford has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Abhishek Chatterjee
Department of Chemistry Boston College Chestnut Hill Massachusetts USA
1 shared publication Andrei Goga
Department of Cell and Tissue Biology and Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
1 shared publicationChester J J Wrobel
Department of Chemistry, Boston College, Chestnut Hill, Massachusetts, USA
1 shared publication- Daniel K. Nomura
University of California, Berkeley
1 shared publication David K. Miyamoto
Departments of Chemistry and Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA
1 shared publicationElizabeth A. Grossman
Departments of Chemistry and Nutritional Sciences and Toxicology, University of California, Berkeley, Berkeley, CA 94720, USA
1 shared publication
Latest Publications
- 13 February 2017
- Published by Springer Nature in Nature Chemical Biology
- Vol. 13 (4) , 446-450
An orthogonalized platform for genetic code expansion in both bacteria and eukaryotes
In this study, we demonstrate the feasibility of expanding the genetic code of Escherichia coli using its own tryptophanyl-tRNA synthetase and tRNA (TrpRS-tRNATrp) pair. This was made possible by first functionally replacing this endogenous pair with an E. coli-optimized counterpart from Saccharomyces cerevisiae, and then reintroducing the liberated E. coli TrpRS-tRNATrp pair into the resulting strain as a nonsense suppressor, which was then followed by its directed evolution to genetically encode several new unnatural amino acids (UAAs). These engineered TrpRS-tRNATrp variants were also able to drive efficient UAA mutagenesis in mammalian cells. Since bacteria-derived aminoacyl-tRNA synthetase (aaRS)-tRNA pairs are typically orthogonal in eukaryotes, our work provides a general strategy to develop additional aaRS-tRNA pairs that can be used for UAA mutagenesis of proteins expressed in both E. coli and eukaryotes.
- 13 February 2017
- Published by Springer Nature in Nature Chemical Biology
- Vol. 13 (4) , 446-450
An orthogonalized platform for genetic code expansion in both bacteria and eukaryotes
In this study, we demonstrate the feasibility of expanding the genetic code of Escherichia coli using its own tryptophanyl-tRNA synthetase and tRNA (TrpRS-tRNATrp) pair. This was made possible by first functionally replacing this endogenous pair with an E. coli-optimized counterpart from Saccharomyces cerevisiae, and then reintroducing the liberated E. coli TrpRS-tRNATrp pair into the resulting strain as a nonsense suppressor, which was then followed by its directed evolution to genetically encode several new unnatural amino acids (UAAs). These engineered TrpRS-tRNATrp variants were also able to drive efficient UAA mutagenesis in mammalian cells. Since bacteria-derived aminoacyl-tRNA synthetase (aaRS)-tRNA pairs are typically orthogonal in eukaryotes, our work provides a general strategy to develop additional aaRS-tRNA pairs that can be used for UAA mutagenesis of proteins expressed in both E. coli and eukaryotes.
- 1 May 2016
- Published by Elsevier in Cell Chemical Biology
- Vol. 23 (5) , 567-578
GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity
- 1 May 2016
- Published by Elsevier in Cell Chemical Biology
- Vol. 23 (5) , 567-578
GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity
- 22 April 2016
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 12 (6) , 1768-1771
A tyrosine-reactive irreversible inhibitor for glutathione S -transferase Pi (GSTP1)
Glutathione S-transferase Pi (GSTP1) mediates cellular defense against reactive electrophiles. Here, we report LAS17, a dichlorotriazine-containing compound that irreversibly inhibits GSTP1 and is selective for GSTP1 within cellular proteomes. Mass spectrometry and mutational studies identified Y108 as the site of modification, providing a unique mode of GSTP1 inhibition.
- 22 April 2016
- Published by Oxford University Press (OUP) in Molecular BioSystems
- Vol. 12 (6) , 1768-1771
A tyrosine-reactive irreversible inhibitor for glutathione S -transferase Pi (GSTP1)
Glutathione S-transferase Pi (GSTP1) mediates cellular defense against reactive electrophiles. Here, we report LAS17, a dichlorotriazine-containing compound that irreversibly inhibits GSTP1 and is selective for GSTP1 within cellular proteomes. Mass spectrometry and mutational studies identified Y108 as the site of modification, providing a unique mode of GSTP1 inhibition.